Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadin for Sleep Disturbances in Children with Neurodevelopmental Disabilities
NCT01906866Phase 3Completed
- Sponsor
- Neurim Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of melatonin in sleep disorder, sponsored by Neurim Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT01906866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906866.